potassium channels
2 drugs Cardiovascular
5
approved indications
2
Approved Drugs
2
Companies
6
Indications
1
Therapeutic Areas
Top Drugs
Unlock Full Target Intelligence PRO
✓ Competitive landscape by company (2 companies)
✓ All 2 approved drugs
✓ Therapeutic area breakdown
✓ Full indication list (6 indications)
✓ Patent cliff analysis
✓ Clinical trials pipeline
Upgrade to Pro
Starting at $99/mo
Drugs by Company
GLENMARK PHARMS LTD 1 drug
Novartis 1 drug
By Therapeutic Area
Cardiovascular 1 drugs
Other 1 drugs
Drugs by Company PRO
GLENMARK PHARMS LTD 1 drug
Novartis 1 drug
By Therapeutic Area
Cardiovascular 1 drugs
PROPAFENONE HYDROCHLORIDE
Other 1 drugs
TRILEPTAL
Indications Treated
Atrial FibrillationAtrial FlutterSupraventricular TachycardiaVentricular TachycardiaVentricular ArrhythmiasPartial-Onset Seizures
All Drugs Targeting potassium channels
| Drug | Company | Approved | Indications | Therapeutic Area |
|---|---|---|---|---|
| PROPAFENONE HYDROCHLORIDE | GLENMARK PHARMS LTD | 2000 | 5 | Cardiovascular |
| TRILEPTAL | Novartis | 2000 | 1 |